Clinical Trial Update: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating an oral short-course regimen that includes bedaquiline for multidrug-resistant tuberculosis in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Multidrug-resistant

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Multidrug-Resistant | Phase 4 | Status: UNKNOWN